Coronavirus 19 presenting with atypical Sweet's syndrome

Taşkın, Banu; Vural, Seçil; Altuğ, Elif; Demirkesen, Cüyan; Kocatürk, Emek; Çelebi, İrfan; Ferhanoğlu, Burhan; Alper, Sibel

doi:10.1111/jdv.16662

Cited by 37 publications

(39 citation statements)

References 9 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…An atypical Sweet syndrome, characterized by erythema nodosum‐like indurated painful nodules, occurred in a 61-year-old Turkish woman, with a one-week history of fever, fatigue, arthralgia, and oral ulcers. 78 Histopathologic study showed a superficial and deep neutrophilic dermatosis. SARS-CoV-2 testing was initially negative but became positive during hospitalization.…”

Section: Resultsmentioning

confidence: 97%

Clinicopathologic correlations of COVID-19–related cutaneous manifestations with special emphasis on histopathologic patterns

Rongioletti

Ferreli

Sena

et al. 2021

Clinics in Dermatology

View full text Add to dashboard Cite

Section: Resultsmentioning

confidence: 97%

Clinicopathologic correlations of COVID-19–related cutaneous manifestations with special emphasis on histopathologic patterns

Rongioletti

Ferreli

Sena

et al. 2021

Clinics in Dermatology

View full text Add to dashboard Cite

“…Our systematic review of the literature identified 56 articles (including our series) evaluating 1020 patients (Table 1, WHOLE cohort) between 1 December 2019 and 9 of May 2020. [2][3][4][5][6][7][8][9][10] Diagnosis of COVID-19 infection was confirmed in 47% of patients (Table 1, CONFIRMED cohort). The female-tomale ratio was 1.1 in both cohorts.…”

mentioning

confidence: 99%

“…We retrieved six series, including ours, in which the numbers of both infected patients and patients with skin signs were available. 4,6,7,9,10 Cutaneous lesions were observed in 38 patients over 2199 COVID-19 cases. Therefore, the mean incidence of cutaneous manifestations in COVID-19 patients was 1.7% (Fig.…”

mentioning

confidence: 99%

Relapsing symmetric livedo reticularis in a patient with COVID‐19 infection

Verheyden

Grosber

Gutermuth

et al. 2020

Acad Dermatol Venereol

View full text Add to dashboard Cite

During the Coronavirus 2019 (COVID‐19) pandemic, several associated skin conditions were reported in infected patients, including; urticaria [1], exanthema [1], erythema multiforme [2], chickenpox‐like vesicles [1], pityriasis rosea [3], herpes simplex reactivation [4], erythema nodosum like Sweet’s syndrome [5], Symmetrical Drug‐Related Intertriginous and Flexural Exanthema [6], petechial rash [7], vasculitic purpura [7], acro‐ischemia/necrosis [8], Kawasaki disease [2] and chilblain lesions [9].

show abstract

“…Some of these, were just suspected COVID‐19 cases, so the relationship with SARS‐CoV‐2 infection can not been properly stated. However, other cases have been published, 15,31‐34 and we have seen other COVID‐19 cases with cutaneous manifestations resembling erythema elevatum diutinum, with histopathological study confirming lymphocytic vasculitis in the biopsy (unpublished data). As a consequence, cutaneous vasculitis should also be considered as a manifestation of SARS‐COV‐2 infection during the pandemic.…”

Section: Discussionmentioning

confidence: 53%

Maculopapular eruptions associated to COVID ‐19: A subanalysis of the COVID‐Piel study

Català

Galván-Casas

Carretero‐Hernández

et al. 2020

Dermatologic Therapy

View full text Add to dashboard Cite

Background A previous study has defined the maculopapular subtype of manifestations of COVID‐19. Objectives To describe and classify maculopapular eruptions associated with COVI‐19. Methods We carried out a subanalysis of the maculopapular cases found in the previous cross‐sectional study. Using a consensus, we defined 7 clinical patterns. We described patient demographics, the therapy received by the patient and the characteristics of each pattern. Results Consensus lead to the description of 7 major maculopapular patterns: Morbilliform (45.5%), Other maculopapular (20.0%), Purpuric (14.2%), Erythema multiforme‐like (9.7%), Pytiriasis rosea‐like (5.7%), Erythema elevatum diutinum‐like (2.3%) and Perifollicular (2.3%). In most cases, maculopapular eruptions were coincident (61.9%) or subsequent (34.1%) to the onset of other COVID‐19 manifestations. The most frequent were cough (76%), dyspnea (72%), fever (88%), and astenia (62%). Hospital admission due to pneumonia was frequent (61%). Drug intake was frequent (78%). Laboratory alterations associated with maculo‐papular eruptions were high C‐reactive protein, high D‐Dimer, lymphopenia, high ferritin, high LDH, and high IL‐6. Limitations The impossibility to define the cause–effect relationship of each pattern. Conclusion We provide a description of the cutaneous maculopapular manifestations associated with COVID‐19. The cutaneous manifestations of COVID‐19 are wide‐ranging and can mimic other dermatoses. This article is protected by copyright. All rights reserved.

show abstract

Coronavirus 19 presenting with atypical Sweet's syndrome

Cited by 37 publications

References 9 publications

Clinicopathologic correlations of COVID-19–related cutaneous manifestations with special emphasis on histopathologic patterns

Clinicopathologic correlations of COVID-19–related cutaneous manifestations with special emphasis on histopathologic patterns

Relapsing symmetric livedo reticularis in a patient with COVID‐19 infection

Maculopapular eruptions associated to COVID ‐19: A subanalysis of the COVID‐Piel study

Contact Info

Product

Resources

About